Takashi Uebanso

Dr. Takashi Uebanso


Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 August 2020 in Molecular Nutrition & Food Research
Verified
Journal Article
Closed access
PDF file
TUTakashi Uebanso
Takashi Uebanso
TSTakaaki Shimohata
Takaaki Shimohata
KMKazuaki Mawatari
Kazuaki Mawatari
ATAkira Takahashi
Akira Takahashi

1 June 2017 in Nutrients
Verified
Journal Article
Open access
PDF file
TUTakashi Uebanso
Takashi Uebanso
AOAi Ohnishi
Ai Ohnishi
RKReiko Kitayama
Reiko Kitayama
AYAyumi Yoshimoto
Ayumi Yoshimoto
TSTakaaki Shimohata
Takaaki Shimohata
ATAkira Takahashi
Akira Takahashi
: Non-caloric artificial sweeteners (NASs) provide sweet tastes to food without adding calories or glucose. NASs can be used as alternative sweeteners for controlling blood glucose levels and weight gain. Although the consumption of NASs has increased over the past decade in Japan and other countries, whether these sweeteners affect the composition of the gut microbiome is unclear. In the present study, we examined the effects of sucralose or acesulfame-K ingestion (at most the maximum acceptable daily intake (ADI) levels, 15 mg/kg body weight) on the gut microbiome in mice. Consumption of sucralose, but not acesulfame-K, for 8 weeks reduced the relative amount of Clostridium cluster XIVa in feces. Meanwhile, sucralose and acesulfame-K did not increase food intake, body weight gain or liver weight, or fat in the epididymis or cecum. Only sucralose intake increased the concentration of hepatic cholesterol and cholic acid. Moreover, the relative concentration of butyrate and the ratio of secondary/primary bile acids in luminal metabolites increased with sucralose consumption in a dose-dependent manner. These results suggest that daily intake of maximum ADI levels of sucralose, but not acesulfame-K, affected the relative amount of the Clostridium cluster XIVa in fecal microbiome and cholesterol bile acid metabolism in mice.

14 July 2017 in Nutrients
Verified
Journal Article
Open access
PDF file
TUTakashi Uebanso
Takashi Uebanso
SKSaki Kano
Saki Kano
AYAyumi Yoshimoto
Ayumi Yoshimoto
CNChisato Naito
Chisato Naito
TSTakaaki Shimohata
Takaaki Shimohata
ATAkira Takahashi
Akira Takahashi
The sugar alcohol xylitol inhibits the growth of some bacterial species including Streptococcus mutans. It is used as a food additive to prevent caries. We previously showed that 1.5–4.0 g/kg body weight/day xylitol as part of a high-fat diet (HFD) improved lipid metabolism in rats. However, the effects of lower daily doses of dietary xylitol on gut microbiota and lipid metabolism are unclear. We examined the effect of 40 and 200 mg/kg body weight/day xylitol intake on gut microbiota and lipid metabolism in mice. Bacterial compositions were characterized by denaturing gradient gel electrophoresis and targeted real-time PCR. Luminal metabolites were determined by capillary electrophoresis electrospray ionization time-of-flight mass spectrometry. Plasma lipid parameters and glucose tolerance were examined. Dietary supplementation with low- or medium-dose xylitol (40 or 194 mg/kg body weight/day, respectively) significantly altered the fecal microbiota composition in mice. Relative to mice not fed xylitol, the addition of medium-dose xylitol to a regular and HFD in experimental mice reduced the abundance of fecal Bacteroidetes phylum and the genus Barnesiella, whereas the abundance of Firmicutes phylum and the genus Prevotella was increased in mice fed an HFD with medium-dose dietary xylitol. Body composition, hepatic and serum lipid parameters, oral glucose tolerance, and luminal metabolites were unaffected by xylitol consumption. In mice, 40 and 194 mg/kg body weight/day xylitol in the diet induced gradual changes in gut microbiota but not in lipid metabolism.

3 October 2018 in Diabetologia
Verified
Journal Article
Closed access
PDF file
TNTakao Nammo
Takao Nammo
HUHaruhide Udagawa
Haruhide Udagawa
NFNobuaki Funahashi
Nobuaki Funahashi
MKMiho Kawaguchi
Miho Kawaguchi
TUTakashi Uebanso
Takashi Uebanso
KYKazuki Yasuda
Kazuki Yasuda

8 July 2020 in Microorganisms
Verified
Journal Article
Open access
PDF file
MKMizuki Kojima
Mizuki Kojima
KMKazuaki Mawatari
Kazuaki Mawatari
TETakahiro Emoto
Takahiro Emoto
RNRisa Nishisaka-Nonaka
Risa Nishisaka-Nonaka
TBThi Kim Ngan Bui
Thi Kim Ngan Bui
ATAkira Takahashi
Akira Takahashi
Influenza A viruses (IAVs) pose a serious global threat to humans and their livestock. This study aimed to determine the ideal irradiation by ultraviolet-light emitting diodes (UV-LEDs) for IAV disinfection. We irradiated the IAV H1N1 subtype with 4.8 mJ/cm2 UV using eight UV-LEDs [peak wavelengths (WL) = 365, 310, 300, 290, 280, 270, and 260 nm)] or a mercury low pressure (LP)-UV lamp (Peak WL = 254 nm). Inactivation was evaluated by the infection ratio of Madin–Darby canine kidney (MDCK) cells or chicken embryonated eggs. Irradiation by the 260 nm UV-LED showed the highest inactivation among all treatments. Because the irradiation-induced inactivation effects strongly correlated with damage to viral RNA, we calculated the correlation coefficient (RAE) between the irradiant spectrum and absorption of viral RNA. The RAE scores strongly correlated with the inactivation by the UV-LEDs and LP-UV lamp. To increase the RAE score, we combined three different peak WL UV-LEDs (hybrid UV-LED). The hybrid UV-LED (RAE = 86.3) significantly inactivated both H1N1 and H6N2 subtypes to a greater extent than 260 nm (RAE = 68.6) or 270 nm (RAE = 42.2) UV-LEDs. The RAE score is an important factor for increasing the virucidal effects of UV-LED irradiation.

15 September 2015 in Journal of Bacteriology
Verified
Journal Article
Open access
PDF file
Phan Ngoc QuangPhan Ngoc Quang
Phan Ngoc Quang
TUTakashi Uebanso
Takashi Uebanso
TSTakaaki Shimohata
Takaaki Shimohata
MNMutsumi Nakahashi
Mutsumi Nakahashi
KMKazuaki Mawatari
Kazuaki Mawatari
ATAkira Takahashi
Akira Takahashi
HU is one of the most abundant nucleoid-associated proteins in bacterial cells and regulates the expression of many genes involved in growth, motility, metabolism, and virulence. It is known that Vibrio parahaemolyticus pathogenicity is related to its characteristic rapid growth and that type III secretion system 1 (T3SS1) contributes to its cytotoxicity. However, it is not known if HU plays a role in the pathogenicity of V. parahaemolyticus . In the present study, we investigated the effect of HU proteins HU-2 (HUα) ( V. parahaemolyticus 2911 [vp2911]) and HUβ (vp0920) on the pathogenicity of V. parahaemolyticus . We found that a deletion of both HU subunits (yielding the ΔHUs [Δ vp0920 Δ vp2911 ] strain), but not single deletions, led to a reduction of the growth rate. In addition, expression levels of T3SS1-related genes, including exsA (positive regulator), exsD (negative regulator), vp1680 (cytotoxic effector), and vp1671 (T3SS1 apparatus), were reduced in the ΔHUs strain compared to the wild type (WT). As a result, cytotoxicity to HeLa cells was decreased in the ΔHUs strain. The additional deletion of exsD in the ΔHUs strain restored T3SS1-related gene expression levels and cytotoxicity but not the growth rate. These results suggest that the HU protein regulates the levels of T3SS1 gene expression and cytotoxicity in a growth rate-independent manner. IMPORTANCE Nucleoid-binding protein HU regulates cellular behaviors, including nucleoid structuring, general recombination, transposition, growth, replication, motility, metabolism, and virulence. It is thought that both the number of bacteria and the number of virulence factors may affect the pathogenicity of bacteria. In the present study, we investigated which factor(s) has a dominant role during infection in one of the most rapidly growing bacterial species, Vibrio parahaemolyticus . We found that V. parahaemolyticus cytotoxicity is regulated, in a growth rate-independent manner, by the HU proteins through regulation of a number of virulence factors, including T3SS1 gene expression.